Teva Pharmaceuticals
U.S. Headquarters
1090 Horsham Road
North Wales
Pennsylvania
19454
United States
Tel: 888-838-2872
Website: https://www.tevausa.com/
1780 articles about Teva Pharmaceuticals
-
Teva Pharmaceutical Industries Limited: Initiation of Enrollment in Pivotal Phase III Clinical Study of Oral Laquinimod for Relapsing-Remitting Multiple Sclerosis
11/7/2007
-
Teva Pharmaceutical Industries Limited: First Patient Undergoes Expanded Cord Blood Transplant in the ExCell Registration Study of StemEx(R) for Leukemia and Lymphoma
11/6/2007
-
Teva Pharmaceutical Industries Limited's CFO to Retire Next Year
10/30/2007
-
Teva Pharmaceutical Industries Limited Reports Third Quarter 2007 Results
10/30/2007
-
Teva Pharmaceutical Industries Limited: COPAXONE® Significantly Decreases Disease Activity in Patients Who Switched from Interferon Beta (IFNb) Due to Development of Neutralizing Antibodies (NAbs)
10/23/2007
-
Adenoscan(R) Patent Lawsuits Settled Astellas Pharma US, Inc., King Pharmaceuticals®, Inc. and Item Finalize Settlement Agreement with Teva Pharmaceutical Industries Limited
10/22/2007
-
Teva Pharmaceutical Industries Limited to Report Third Quarter 2007 Financial Results on October 30, 2007
10/17/2007
-
Teva Pharmaceutical Industries Limited Calls 0.375% Remaining Convertible Debentures Due 2022 for Redemption
10/16/2007
-
Teva Pharmaceutical Industries Limited: Long-Term Study Shows COPAXONE(R) Significantly Slows Progression of Disability and Reduces Relapse Rates in Patients with Relapsing-Remitting Multiple Sclerosis
10/12/2007
-
Teva Pharmaceutical Industries Limited Announces Approval of Generic Actonel(R)
10/8/2007
-
Teva Pharmaceutical Industries Limited Announces Tentative Approval of Generic Valtrex(R)
10/5/2007
-
Teva Pharmaceutical Industries Limited Announces Court of Appeals Denies Novartis International AG's Emergency Motion on Generic Famvir(R)
10/1/2007
-
Teva Pharmaceutical Industries Limited Announces Settlement of Generic Avandia(R), Avandamet(R), and Avandaryl(R) Litigation with GlaxoSmithKline
9/28/2007
-
Teva Pharmaceutical Industries Limited Provides Update on Generic Neurontin(R) Litigation
9/21/2007
-
Teva Pharmaceutical Industries Limited's Edratide for Systemic Lupus Erythematosus Did Not Meet Its Primary Endpoint in Phase 2 Trial
9/19/2007
-
Teva Pharmaceutical Industries Limited Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
9/17/2007
-
Roche Sues Teva Pharmaceutical Industries Limited in U.S. Over Generic Bone Drug
9/11/2007
-
Teva Pharmaceutical Industries Limited Says Court Temporarily Halts Famciclovir Sales
9/10/2007
-
Teva Pharmaceutical Industries Limited Receives Favorable Court Decision Regarding Generic Protonix(R) Tablets; Motion for Preliminary Injunction Denied
9/7/2007
-
Teva Pharmaceutical Industries Limited Announces Launch of Generic Famvir(R) Tablets
9/7/2007